News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Provence Technologies Increases Its Capital to EUR One Million


9/5/2012 12:02:25 PM

Marseille, France, September 5, 2012 – Provence Technologies, a research company specialized in fine chemistry, announces today that it has increased its capital by EUR 800,000 to EUR one million through a transfer from reserves. The company has greatly strengthened its financial structure since it was founded in 1998 and has succeeded in creating a solid shareholder base.

“We are particularly happy about this capital increase, which confirms our shareholders’ confidence in the future of Provence Technologies,” said Christophe Baralotto, the company’s CFO. “For all our partners, suppliers and clients, the increase is a guarantee of sustainability.”

Provence Technologies combines a traditional CRO (contract research organization) business for clients in the pharmaceutical, agrochemical and cosmetics industries with a high-value-added research activity based on its innovative technologies. Thanks to this balanced business model, the company has funded its research programs through its fee-for-service activities and has thus created a virtuous circle, with revenues derived from its own products. Provence Technologies is thus pushing ahead with research and development programs focused on compounds which are known for their high therapeutic potential but which have been neglected or abandoned up to now because of poor quality.

“The increased capital will enable Provence Technologies to support its growth strategy and fully develop its R&D programs,” said the company’s chairman, Michel Feraud. “Since it was founded, our company has sought, among other projects, to uncover the therapeutic potential of abandoned compounds, as it did with methylene blue. We want to continue down this path, which not only creates value for the company but also gives patients the benefit of these drugs.”

To carry this R&D strategy forward, two new researchers will join Provence Technologies at the end of 2012. The company is also planning to move into a new 1,600 square meter building in the Chateau-Gombert technology park in Marseille in 2013.

About Provence Technologies

Provence Technologies is an independent company that provides R&D services in the area of fine chemistry to the pharmaceutical, agrochemical and cosmetics industries, including the search for synthetic pathways, the synthesis of organic compounds and the development and optimization of chemical processes.

The company also provides services for the development and validation of analytical methods. Thanks to its unique knowhow and its proprietary research and development programs, Provence Technologies offers its customers tailor-made and innovative technical solutions and supports them from early-stage drug discovery as far as the pre-industrialization stage.

Founded in 1998 and based in Marseille, Provence Technologies employs around ten people and generated revenues of EUR two million in 2011.

For further information, go to: http://www.provetech.com

Mark Tidmarsh

ANDREW LLOYD & ASSOCIATES

http://www.ala.com

mark@ala.com

Follow us on Twitter: https://twitter.com/ALA_Group

Brighton Business Centre 95 Ditchling Road Brighton BN1 4ST ENGLAND

Tel: +44 1273 675100 Fax: +44 1273 675400

55 rue Boissonade 75014 Paris FRANCE

Tel: +33 1 56 54 07 00 Fax: +33 1 56 54 07 01

INTERNATIONAL TECHNOLOGY MARKETS, STRATEGY & COMMUNICATION


Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES